FDA "REFERENCE LIST" VIOLATES CONSTITUTIONAL DUE PROCESS PROTECTIONS
This article was originally published in The Gray Sheet
FDA "REFERENCE LIST" VIOLATES CONSTITUTIONAL DUE PROCESS PROTECTIONS and should be revoked, the Washington, D.C. law firm Hyman, Phelps & McNamara argues in a Sept. 2 citizens' petition. FDA's use of a reference list of companies with outstanding violations of good manufacturing practices and other regulations deprives those companies of rights to adequate notice and opportunity to be heard, property rights, and liberty interests guaranteed by the Constitution, the firm asserts.
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.